Journal of Cellular Physiology
RAPID COMMUNICATION
Full Access

TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines

Alfredo I. Sagredo

Facultad de Medicina, Centro de Investigación y Tratamiento del Cáncer, Universidad de Chile, Chile

Search for more papers by this author
Eduardo A. Sagredo

Facultad de Medicina, Centro de Investigación y Tratamiento del Cáncer, Universidad de Chile, Chile

Search for more papers by this author
Victor Pola

Departamento de Oncología Básico‐Clínica, Facultad de Medicina, Universidad de Chile, Chile

Search for more papers by this author
César Echeverría

Facultad de Medicina, Centro de Investigación y Tratamiento del Cáncer, Universidad de Chile, Chile

Facultad de Medicina, Universidad de Atacama, Copiapo, Chile

Search for more papers by this author
Rodrigo Andaur

Departamento de Oncología Básico‐Clínica, Facultad de Medicina, Universidad de Chile, Chile

Search for more papers by this author
Luis Michea

Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Chile

Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Search for more papers by this author
Andrés Stutzin

Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de Chile, Chile

Search for more papers by this author
Felipe Simon

Departamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago, Chile

Millennium Institute on Immunology and Immunotherapy, Santiago, Chile

Search for more papers by this author
Katherine Marcelain

Corresponding Author

E-mail address: kmarcelain@med.uchile.cl

Facultad de Medicina, Centro de Investigación y Tratamiento del Cáncer, Universidad de Chile, Chile

Departamento de Oncología Básico‐Clínica, Facultad de Medicina, Universidad de Chile, Chile

Correspondence Katherine Marcelain and Ricardo Armisén, Centro de Investigación y Tratamiento del Cáncer, Facultad de Medicina, Universidad de Chile, Chile. Email: kmarcelain@med.uchile.cl (K.M); ricardo.armisen@pfizer.com (R.A)

Search for more papers by this author
Ricardo Armisén

Corresponding Author

E-mail address: ricardo.armisen@pfizer.com

Facultad de Medicina, Centro de Investigación y Tratamiento del Cáncer, Universidad de Chile, Chile

Departamento de Oncología Básico‐Clínica, Facultad de Medicina, Universidad de Chile, Chile

Correspondence Katherine Marcelain and Ricardo Armisén, Centro de Investigación y Tratamiento del Cáncer, Facultad de Medicina, Universidad de Chile, Chile. Email: kmarcelain@med.uchile.cl (K.M); ricardo.armisen@pfizer.com (R.A)

Search for more papers by this author
First published: 21 October 2018
Citations: 7

Present address: Eduardo A. Sagredo and Ricardo Armisén, Center of Excellence in Precision Medicine Pfizer Chile, Obispo Arturo Espinoza Campos 2526, Macul, Santiago, Chile

Get access to the full version of this article. View access options below.
Institutional Login
Loading institution options...

If you have previously obtained access with your personal account, .

    • View the article PDF and any associated supplements and figures for a period of 48 hours.
    • Article can not be printed.
    • Article can not be downloaded.
    • Article can not be redistributed.
    • Unlimited viewing of the article PDF and any associated supplements and figures.
    • Article can not be printed.
    • Article can not be downloaded.
    • Article can not be redistributed.
    • Unlimited viewing of the article/chapter PDF and any associated supplements and figures.
    • Article/chapter can be printed.
    • Article/chapter can be downloaded.
    • Article/chapter can not be redistributed.

Abstract

Transient Receptor Potential Melastatin 4 (TRPM4) is a Ca2+‐activated and voltage‐dependent monovalent cation channel, which depolarizes the plasma cell membrane, thereby modulating Ca2+ influx across Ca2+‐permeable pathways. TRPM4 is involved in different physiological processes such as T cell activation and the migration of endothelial and certain immune cells. Overexpression of this channel has been reported in various types of tumors including prostate cancer. In this study, a significant overexpression of TRPM4 was found only in samples from cancer with a Gleason score higher than 7, which are more likely to spread. To evaluate whether TRPM4 overexpression was related to the spreading capability of tumors, TRPM4 was knockdown by using shRNAs in PC3 prostate cancer cells and the effect on cellular migration and invasion was analyzed. PC3 cells with reduced levels of TRPM4 (shTRPM4) display a decrease of the migration/invasion capability. A reduction in the expression of Snail1, a canonical epithelial to mesenchymal transition (EMT) transcription factor, was also observed. Consistently, these cells showed a significant change in the expression of key EMT markers such as MMP9, E‐cadherin/N‐cadherin, and vimentin, indicating a partial reversion of the EMT process. Whereas, the overexpression of TRPM4 in LnCaP cells resulted in increased levels of Snail1, reduction in the expression of E‐cadherin and increase in their migration potential. This study suggests a new and indirect mechanism of regulation of migration/invasion process by TRPM4 in prostate cancer cells, by inducing the expression of Snail1 gene and consequently, increasing the EMT.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.